• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Silence Therapeutics Plc - American Depository Share (NQ:SLN)

4.930 -0.380 (-7.16%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Silence Therapeutics Plc - American Depository Share

< Previous 1 2 3 4 5 6 Next >
Top stock movements in today's session. ↗
Today 16:00 EDT
Via Chartmill
Keep an eye on the top gainers and losers in Friday's session. ↗
Today 13:30 EDT
Via Chartmill
Which stocks are gapping on Friday? ↗
Today 11:30 EDT
Via Chartmill
Top movers analysis one hour before the close of the markets on 2026-03-26: top gainers and losers in today's session. ↗
March 26, 2026
Via Chartmill
News headline image
Deep Dive Into Silence Therapeutics Stock: Analyst Perspectives (7 Ratings) ↗
March 04, 2025
 
Via Benzinga
News headline image
Earnings Scheduled For February 27, 2025 ↗
February 27, 2025
 
Via Benzinga
Here are the top movers in Thursday's session. ↗
March 26, 2026
Via Chartmill
These stocks that are showing activity before the opening bell on Thursday. ↗
March 26, 2026
Via Chartmill
Top movers in Friday's session ↗
March 20, 2026
Via Chartmill
Which stocks are moving on Thursday? ↗
March 12, 2026
Via Chartmill
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
March 05, 2026
Via Chartmill
News headline image
Silence Therapeutics Highlights Recent Business Achievements and Reports Fourth Quarter and Full Year 2025 Financial Results
March 05, 2026
From Silence Therapeutics plc
Via Business Wire
News headline image
Silence Therapeutics Announces Leadership Changes
December 15, 2025
From Silence Therapeutics plc
Via Business Wire
News headline image
Bausch Health’s Slow Rebuild Faces New Scrutiny After Lombard Odier Cuts Its Stake ↗
December 10, 2025
Bausch Health’s valuation suggests potential, but the stake cut shows how far the company still has to go to earn back full investor confidence. 
Via The Motley Fool
News headline image
Silence Therapeutics to Participate in Fireside Chat at Jefferies Global Healthcare Conference
November 12, 2025
From Silence Therapeutics plc
Via Business Wire
News headline image
Silence Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights
November 06, 2025
From Silence Therapeutics plc
Via Business Wire
News headline image
Silence Therapeutics Completes Enrollment in SANRECO Phase 2 Study of Divesiran for Polycythemia Vera (PV)
October 23, 2025
From Silence Therapeutics plc
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
October 21, 2025
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
October 21, 2025
 
Via Benzinga
News headline image
Silence Therapeutics to Participate in September Investor Conferences
September 02, 2025
From Silence Therapeutics plc
Via Business Wire
News headline image
Silence (SLN) Q2 Revenue Drops 71% ↗
August 07, 2025
Via The Motley Fool
News headline image
Silence Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights
August 07, 2025
From Silence Therapeutics plc
Via Business Wire
News headline image
Silence Therapeutics Presents Additional Phase 1 Data Highlighting Promise of Divesiran as the Potential First-in-Class siRNA Treatment for Polycythemia Vera
June 12, 2025
From Silence Therapeutics plc
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
June 03, 2025
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
May 13, 2025
Via Benzinga
News headline image
Silence Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights
May 08, 2025
From Silence Therapeutics plc
Via Business Wire
News headline image
Silence Therapeutics Welcomes Tim McInerney to Board of Directors
May 06, 2025
From Silence Therapeutics plc
Via Business Wire
News headline image
These stocks are moving in today's pre-market session ↗
April 01, 2025
Discover the top movers in Tuesday's pre-market session and stay informed about market dynamics. 
Via Chartmill
News headline image
Silence Therapeutics to Webcast Presentation at the Leerink Partners Global Healthcare Conference
March 05, 2025
From Silence Therapeutics plc
Via Business Wire
News headline image
Silence Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
February 27, 2025
From Silence Therapeutics plc
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap